User:Mr. Ibrahem/Dulaglutide

Dulaglutide, sold under the brand name Trulicity among others, is a medication used to treat type 2 diabetes. Among those in this group at high risk, it may decrease the risk of heart disease. It is used together with diet and exercise. It is give once weekly by injection under the skin.

Common side effects include nausea, diarrhea, vomiting, abdominal pain, and decreased appetite. Other side effects may include pancreatitis, low blood sugar, allergic reactions, kidney problems, and certain thyroid tumors. It is a glucagon-like peptide-1 receptor agonist (GLP-1 agonist) which increases the amount of insulin released by the pancreas in response to food.

Dulaglutide was approved for medical use in the United States and Europe in 2014. In the United Kingdom it costs the NHS about £73 every 4 weeks at a dose of 1.5 mg. This amount in the United States costs about 735 USD. In 2018, it was the 149th most commonly prescribed medication in the United States, with more than 4million prescriptions.